Prelude Capital Management’s SeaStar Medical ICU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-47
Closed -$118K 1926
2022
Q1
$118K Hold
47
﹤0.01% 1380
2021
Q4
$117K Hold
47
﹤0.01% 1685
2021
Q3
$117K Sell
47
-11
-19% -$27.3K ﹤0.01% 1476
2021
Q2
$144K Hold
58
﹤0.01% 1423
2021
Q1
$143K Buy
+58
New +$142K ﹤0.01% 1383

Other funds holding ICU

Prelude Capital Management's ICU Position: Q2 2022 in Review

Prelude Capital Management sold out of SeaStar Medical (ICU) in Q2 2022, closing a stake of 47 shares — an estimated $118K sold.

Prelude Capital Management first reported a position in ICU in Q1 2021 and held it in 5 quarters. The position peaked at $144K in Q2 2021. 47 funds tracked by Wall St. Rank hold ICU as of Q2 2022.

  • Prelude Capital Management reported no remaining SeaStar Medical position as of Q2 2022 after selling out during the quarter.
  • Prelude Capital Management sold 47 SeaStar Medical shares in Q2 2022, an estimated $118K.
  • Prelude Capital Management first reported a position in SeaStar Medical in Q1 2021 and held it in 5 quarters.
  • Prelude Capital Management's SeaStar Medical position peaked at $144K in Q2 2021.
  • 47 funds tracked by Wall St. Rank held SeaStar Medical as of Q2 2022.

Based on Prelude Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.